Basal cell carcinoma (BCC) is the most common form of skin cancer, accounting for about 80% of all skin cancer cases. It is usually found on areas of the body that have been exposed to the sun, such as the face, neck, arms, and legs. BCC is a slow-growing cancer that is rarely fatal, but can cause significant disfigurement if not treated promptly. Despite its prevalence, the exact cause of BCC is still not fully understood. In this article, we will explore what is known about BCC, what is still unknown, and the latest treatments and management strategies.
BCC is a type of non-melanoma skin cancer caused by long-term exposure to ultraviolet radiation (UV) from the sun or tanning beds. The majority of BCCs are found on the face, neck, and scalp. They are usually small, raised, and flesh-colored, but can also appear as flat, scaly patches. BCCs can grow and spread slowly, but rarely metastasize or spread to other organs. The risk of developing BCC increases with age, and it is more common in fair-skinned individuals, those who have had a lot of sun exposure, and those with a history of skin cancer. Other risk factors include a weakened immune system, a family history of skin cancer, and certain genetic disorders.
BCC is typically diagnosed through a physical examination and biopsy. During the biopsy, a sample of tissue is taken from the affected area and examined under a microscope to determine if it is cancerous. If the biopsy confirms BCC, additional tests may be performed to determine the extent of the cancer. Treatment for BCC depends on the size, location, and severity of the cancer. Options include topical creams and ointments, cryosurgery (freezing the cancer cells), radiation therapy, and surgery. In some cases, Mohs micrographic surgery may be used, which involves removing the cancerous cells layer by layer until only healthy tissue remains.
Despite its prevalence, there are still many aspects of BCC that are not fully understood. For example, the exact cause of BCC is still unknown. It is thought to be related to long-term exposure to UV radiation, but other factors may be involved. The exact mechanism by which BCC grows and spreads is also not well understood. Some studies suggest that BCC may be able to spread through the lymphatic system, while others suggest that it is unlikely to spread to other organs. Additionally, there is still much to be learned about the genetic factors that may be involved in the development of BCC. Several genes have been identified as being associated with an increased risk of BCC, but the exact role these genes play is still unclear.
In recent years, there have been a number of advances in the treatment and management of BCC. For example, topical medications such as imiquimod and 5-fluorouracil (5-FU) have been shown to be effective in treating early-stage BCC. Additionally, photodynamic therapy (PDT) is a relatively new treatment that uses light and a special cream to kill cancer cells. In terms of management strategies, it is important for individuals with BCC to practice sun safety. This includes wearing protective clothing and sunscreen, avoiding tanning beds, and avoiding prolonged exposure to the sun. It is also important to regularly check for any suspicious moles or lesions, and to see a dermatologist for regular skin cancer screenings.
Basal cell carcinoma is the most common form of skin cancer, and is usually caused by long-term exposure to UV radiation. While much is known about BCC, there are still many aspects that are not fully understood. Fortunately, advances in treatment and management strategies have made it easier to diagnose and treat BCC, and to reduce the risk of developing it in the first place.
1.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
2.
Six breast texture patterns linked to higher risk of invasive cancer
3.
Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.
4.
Scientists develop scans that light up aggressive cancer tumors for better treatment
5.
Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.
1.
Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment
2.
Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology
3.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
4.
Exploring the Unseen: Carcinoid Syndrome and its Impact on Quality of Life
5.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation